| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/17/2002 | EP1196610A2 Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| 04/17/2002 | EP1196609A2 Catalytically active recombinant memapsin and methods of use thereof |
| 04/17/2002 | EP1196608A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 04/17/2002 | EP1196607A1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 04/17/2002 | EP1196606A1 Lytic enzyme |
| 04/17/2002 | EP1196605A1 Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 04/17/2002 | EP1196604A2 11-arachidonate-lipoxygenase mutants |
| 04/17/2002 | EP1196603A2 Modified cytochrome p450 monooxygenases |
| 04/17/2002 | EP1196602A1 Dihydroorotate dehydrogenase sequence of corynebacterium glutamicum and the use thereof in microbial production of pyrimidine and/or compounds used with pyrimidine |
| 04/17/2002 | EP1196601A1 Compositions and methods for fumonisin detoxification |
| 04/17/2002 | EP1196600A1 Drosophila recombination-associated protein and methods for use |
| 04/17/2002 | EP1196599A2 Maize dna ligase ii orthologue and uses thereof |
| 04/17/2002 | EP1196598A1 Dsp-3 dual-specificity phosphatase |
| 04/17/2002 | EP1196597A2 Linoleate isomerase |
| 04/17/2002 | EP1196596A1 Mosaic infectious bursal disease virus vaccines |
| 04/17/2002 | EP1196595A2 Methods of inducing cell death |
| 04/17/2002 | EP1196594A2 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 04/17/2002 | EP1196593A2 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 04/17/2002 | EP1196592A1 Pyrf gene and the utilization thereof |
| 04/17/2002 | EP1196591A1 Moraxella catarrhalis polypeptides |
| 04/17/2002 | EP1196590A1 Epoxide hydrolases from streptomyces |
| 04/17/2002 | EP1196589A1 Cloning of basb110 antigen from moraxella (branhamella) catarrhalis |
| 04/17/2002 | EP1196588A1 Basb113 polypeptide antigen from moraxella catarrhalis |
| 04/17/2002 | EP1196587A2 Antigenic meningococcal peptides |
| 04/17/2002 | EP1196586A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 04/17/2002 | EP1196585A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 04/17/2002 | EP1196584A1 Tetanus toxin polypeptides |
| 04/17/2002 | EP1196583A2 GENOME SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS $i(ABISSY), FRAGMENT AND USES THEREOF |
| 04/17/2002 | EP1196582A1 Genetic control of flowering using the fwa gene |
| 04/17/2002 | EP1196581A1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained |
| 04/17/2002 | EP1196580A1 MAIZE ORTHOLOGUES OF BACTERIAL RuvB:cDNAS AND USES THEREOF |
| 04/17/2002 | EP1196579A2 Tryptase inhibitor |
| 04/17/2002 | EP1196578A1 Axor39, a g-protein coupled receptor with 7-tm segments |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196576A2 Secreted polypeptides and corresponding polynucleotides |
| 04/17/2002 | EP1196575A2 Gtp-binding protein associated factors |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196573A1 A human lactoferrin produced by using an insect cell and method using the same |
| 04/17/2002 | EP1196572A1 Axor21, a g-protein coupled receptor |
| 04/17/2002 | EP1196571A1 Orbit and homologues thereof |
| 04/17/2002 | EP1196570A2 Human polypeptides and methods for the use thereof |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196566A1 Expression vectors and methods |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196564A2 Atherosclerosis-associated genes |
| 04/17/2002 | EP1196563A2 Novel molecules of the card-related protein family and uses thereof |
| 04/17/2002 | EP1196562A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 04/17/2002 | EP1196561A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
| 04/17/2002 | EP1196559A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 04/17/2002 | EP1196558A1 Immunostimulant oligonucleotide |
| 04/17/2002 | EP1196557A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 04/17/2002 | EP1196556A2 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 04/17/2002 | EP1196555A2 Method for the identification of a receptor |
| 04/17/2002 | EP1196554A1 Methods of cloning and producing fragment chains with readable information content |
| 04/17/2002 | EP1196553A1 Arabidopsis thaliana cyclic nucleotide-gated ion channel dnd genes; regulators of plant disease resistance and cell death |
| 04/17/2002 | EP1196552A2 Methods and compositions for engineering of attenuated vaccines |
| 04/17/2002 | EP1196551A1 Electrical impedance tomography to control electroporation |
| 04/17/2002 | EP1196550A2 Cell/tissue analysis via controlled electroporation |
| 04/17/2002 | EP1196549A1 Controlled electroporation and mass transfer across cell membranes |
| 04/17/2002 | EP1196548A2 Protease conjugates having sterically protected clip sites |
| 04/17/2002 | EP1196545A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 04/17/2002 | EP1196544A2 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/17/2002 | EP1196542A1 Production by yeasts of aspartic proteinases from plant origin with sheep's, cow's, goat's milk, etc. clotting and proteolytic activity |
| 04/17/2002 | EP1196539A1 Substrates for nucleic acid immobilization onto solid supports |
| 04/17/2002 | EP1196448A2 Homomeric and heteromeric ampa receptors |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196439A2 Compounds exhibiting an antibiotic activity |
| 04/17/2002 | EP1196438A1 A ligand of the protein "beacon" |
| 04/17/2002 | EP1196437A1 Fima PILUS-BASED VACCINES |
| 04/17/2002 | EP1196435A1 Recombinant adenovirus |
| 04/17/2002 | EP1196426A1 Cytoplasmic transfer to de-differentiate recipient cells |
| 04/17/2002 | EP1196425A1 Detection of giardia |
| 04/17/2002 | EP1196197A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 04/17/2002 | EP1196196A2 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 04/17/2002 | EP1196191A1 Death domain containing receptor 5 |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196178A1 Covalently closed immunostimulating nucleic acid molecule |
| 04/17/2002 | EP1196027A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 04/17/2002 | EP1196026A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 04/17/2002 | EP1125107A4 Tests for the rapid evaluation of ischemic states and kits |
| 04/17/2002 | EP1121421A4 Materials and methods for the modification of plant lignin content |
| 04/17/2002 | EP1107661A4 Plant fatty acid desaturase promoters |
| 04/17/2002 | EP1056882A4 One dimensional chemical compound arrays and methods for assaying them |
| 04/17/2002 | EP0994726B1 Compositions suitable for delivery of genes to epithelial cells |
| 04/17/2002 | EP0986404B1 Gene therapy delivery system for targeting to endothelia |
| 04/17/2002 | EP0876152B1 Novel administration of thrombopoietin |
| 04/17/2002 | EP0871640A4 Methods for measuring physical characteristics of nucleic acids by microscopic imaging |
| 04/17/2002 | EP0870059B1 Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of hla types |
| 04/17/2002 | EP0852627A4 Cell death protein |
| 04/17/2002 | EP0843725B1 Method for preparing polypeptide variants |
| 04/17/2002 | EP0826047B1 Recombinant baculovirus insecticides |
| 04/17/2002 | EP0793730A4 A high-throughput screening assay for inhibitors of nucleic acid polymerases |
| 04/17/2002 | EP0745135B1 Method for exponential amplification of nucleic acid by a single unpaired primer |
| 04/17/2002 | EP0662827B1 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 04/17/2002 | EP0651784B1 Yeast strains expressing a lactic lacticodeshydrogenase gene and vectors useful in producing said strains |
| 04/17/2002 | EP0607178B1 Methods for the isolation and fusion of cells |